InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Bluestone Jeffrey, Director. Director active across 2 companies, notably Gilead Sciences, INC.. In total, 18 filings have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €1.1m. History available since 5 May 2022. The latest transaction was disclosed on 20 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bluestone Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
1,165 shares@ US$67.45Common StockSEC:0001771814-26-000005:0
1,165 shares@ US$143.7543Common StockSEC:0001771814-26-000005:1
1,816 shares@ US$67.45Common StockSEC:0001771814-26-000005:2
1,816 shares@ US$144.9248Common StockSEC:0001771814-26-000005:3
1,658 shares@ US$67.45Common StockSEC:0001771814-26-000005:4
1,658 shares@ US$145.7286Common StockSEC:0001771814-26-000005:5
26 shares@ US$67.45Common StockSEC:0001771814-26-000005:6
26 shares@ US$146.36Common StockSEC:0001771814-26-000005:7
335 shares@ US$61.35Common StockSEC:0001771814-26-000005:8
335 shares@ US$146.26Common StockSEC:0001771814-26-000005:9
5,000 shares@ US$67.450.0002% mcap50.0% of flowCommon StockSEC:0001771814-26-000002:0
5,000 shares@ US$64.9216.7% of flowCommon StockSEC:0001771814-25-000005:0
5,000 shares@ US$67.4517.2% of flowCommon StockSEC:0001127602-25-019182:0
5,000 shares@ US$109.7427.9% of flowCommon StockSEC:0001127602-25-019182:1
5,879 shares@ US$61.1720.5% of flowCommon StockSEC:0001127602-24-028213:0
2,444 shares0Common StockSEC:0001127602-22-013726:0
2,223 sharesCommon StockSEC:0001127602-22-013129:0
1,041 sharesCommon StockSEC:0001127602-21-030577:0
18 of 18 declarations
About Bluestone Jeffrey
Bluestone Jeffrey is a Director at Gilead Sciences, INC. and Gilead Sciences INC. He has 8 filings in total, and across the 8 recent filings tracked, the activity runs from 2021-12-09 to 2026-01-21, with €0 of purchases and €470329 of sales; the most common transaction nature is Levée d'options.
